NL-OMON38581已完成不适用
A STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3045697 AFTER MULTIPLE ORAL DOSING IN HEALTHY SUBJECTS - ASEB
Chorus, Eli Lilly and company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Healthy males or females (females must be postmenopausal or surgically sterile)
- •-Postmenopausal female subjects must be between the ages of 45 and 65 years, inclusive
- •-Male subjects and surgically sterile females must be between the ages of 18 and 65 years, inclusive
- •-BMI between 18.0 and 32.5 kg/m2 , inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60days before the start of this study or being a blood donor within 60 days from the start of the study. In case ofdonating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
A STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3045697 AFTER SINGLE ORAL DOSING IN HEALTHY SUBJECTSChronic kidney disease10038430Kidney DiseaseNL-OMON38917Chorus, Eli Lilly and company27
尚未招募
1 期
A Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-3505 in Healthy Volunteers (PART II)Neurological - Other neurological disordersMigraineACTRN12624001026516KALLYOPE, Inc.12
尚未招募
1 期
A Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-3505 in Healthy Volunteers (PART I).MigraineACTRN12624000990527KALLYOPE, Inc.28
进行中（未招募）
1 期
A study to investigate the safety and efficacy of TRK-750 for thetreatment of patients with CIPChemotherapy-induced peripheral neuropathyMedDRA version: 20.1Level: LLTClassification code 10079545Term: Chemotherapy induced peripheral neuropathySystem Organ Class: 100000004852EUCTR2019-003561-17-GBToray Industries, Inc.120
进行中（未招募）
1 期
A study to investigate the safety and efficacy of TRK-750 for thetreatment of patients with CIPChemotherapy-induced peripheral neuropathyMedDRA version: 20.1Level: LLTClassification code 10079545Term: Chemotherapy induced peripheral neuropathySystem Organ Class: 100000004852EUCTR2019-003561-17-ESToray Industries, Inc.120